Objective: Investigate a role for calcitonin gene-related peptide (CGRP) in osteoarthritis (OA)-related pain.
Design: Neutralizing antibodies to CGRP were generated de novo. One of these antibodies, LY2951742, was characterized in vitro and tested in pre-clinical in vivo models of OA pain.
Results: LY2951742 exhibited high affinity to both human and rat CGRP (KD of 31 and 246 pM, respectively). The antibody neutralized CGRP-mediated induction of cAMP in SK-N-MC cells in vitro and capsaicin-induced dermal blood flow in the rat. Neutralization of CGRP significantly reduced pain behavior as measured by weight bearing differential in the rat monoiodoacetate model of OA pain in a dose-dependent manner. Moreover, pain reduction with neutralization of CGRP occurred independently of prostaglandins, since LY2951742 and NSAIDs worked additively in the NSAID-responsive version of the model and CGRP neutralization remained effective in the NSAID non-responsive version of the model. Neutralization of CGRP also provided dose-dependent and prolonged (>60 days) pain reduction in the rat meniscal tear model of OA after only a single injection of LY2951742.
Conclusions: LY2951742 is a high affinity, neutralizing antibody to CGRP. Neutralization of CGRP is efficacious in several OA pain models and works independently of NSAID mechanisms of action. LY2951742 holds promise for the treatment of pain in OA patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.joca.2014.01.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Regulatory T cells require peripheral CCL2-CCR2 signaling to facilitate the resolution of medication overuse headache-related behavioral sensitization.
J Headache Pain
November 2024
Department of Anesthesiology, Washington University in St. Louis School of Medicine, St. Louis, MO, 63110, USA.
Article Synopsis
- Medication overuse headache (MOH) occurs from excessive use of headache medication, like sumatriptan, and is linked to changes in the CCL2-CCR2 and CGRP signaling pathways, which may contribute to chronic migraine symptoms.
- The study involved administering sumatriptan to mice for 12 days to observe changes in sensitivity and to evaluate how specific signaling pathways were affected, using both genetic techniques and treatments.
- Results indicated that inhibiting CCL2 and CCR2 signaling did not prevent sumatriptan-induced sensitization, and LD-IL-2 treatment was effective in helping to resolve the sensitization caused by overuse of the medication.
The mode of action of IL-23 in experimental inflammatory arthritic pain and disease.
Arthritis Res Ther
August 2024
Department of Medicine, Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, 3050, Australia.
Objectives: We have previously reported using gene-deficient mice that the interleukin (IL)-23p19 subunit is required for the development of innate immune-driven arthritic pain and disease. We aimed to explore here, using a number of in vivo approaches, how the IL-23p19 subunit can mechanistically control arthritic pain and disease in a T- and B- lymphocyte-independent manner.
Methods: We used the zymosan-induced arthritis (ZIA) model in wild-type and Il23p19 mice, by a radiation chimera approach, and by single cell RNAseq and qPCR analyses, to identify the IL23p19-expressing and IL-23-responding cell type(s) in the inflamed joints.
Monoclonal Antibody Targeting CGRP Relieves Cisplatin-Induced Neuropathic Pain by Attenuating Neuroinflammation.
Neurotox Res
January 2024
Navy Clinical College, The Fifth School of Clinical Medicine, Anhui Medical University, Hefei, Anhui Province, 230032, China.
Chemotherapy-induced neuropathic pain (CIPN) is a common side effect of antitumor chemotherapeutic agents. It describes a pathological state of pain related to the cumulative dosage of the drug, significantly limiting the efficacy of antitumor treatment. Sofas strategies alleviating CIPN still lack.
View Article and Find Full Text PDFRegulation of Axon Guidance by Slit2 and Netrin-1 Signaling in the Lacrimal Gland of Aqp5 Knockout Mice.
Invest Ophthalmol Vis Sci
September 2023
Department of Human Anatomy, Histology and Embryology, School of Basic Medicine, Qingdao University, Qingdao, China.
Purpose: Dry eye disease (DED) is multifactorial and associated with nerve abnormalities. We explored an Aquaporin 5 (AQP5)-deficiency-induced JunB activation mechanism, which causes abnormal lacrimal gland (LG) nerve distribution through Slit2 upregulation and Netrin-1 repression.
Methods: Aqp5 knockout (Aqp5-/-) and wild-type (Aqp5+/+) mice were studied.
Peripheral CCL2-CCR2 signalling contributes to chronic headache-related sensitization.
Brain
October 2023
Department of Anesthesiology and Washington University Pain Center, Washington University School of Medicine, Campus Box MSC 8054-86-05, St. Louis, MO 63110, USA.
Migraine, especially chronic migraine, is highly debilitating and still lacks effective treatment. The persistent headache arises from activation and sensitization of primary afferent neurons in the trigeminovascular pathway, but the underlying mechanisms remain incompletely understood. Animal studies indicate that signalling through chemokine C-C motif ligand 2 (CCL2) and C-C motif chemokine receptor 2 (CCR2) mediates the development of chronic pain after tissue or nerve injury.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!